Company / Shareholders' Equity
Cyclerion Therapeutics, Inc. Shareholders' Equity History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$9.1M
FY2025
5-year range
$9.1M / $59.5M
FY2021-FY2025
Trend
-19.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $10M to $9M over the past 2 years.
Based on SEC 10-K filings.
$9M in FY2025 with a 5-year CAGR of -37.8%.
Declined from $10M to $9M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -4.6%
- 5-Year CAGR
- -37.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -37.8%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 19.5% year-over-year.
- Peak shareholders' equity was recorded in FY2020.
- Lowest shareholders' equity in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -19.82 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.1M | -19.5% |
| FY2024 | $11.3M | +8.0% |
| FY2023 | $10.5M | +0.0% |
| FY2022 | $10.5M | -82.4% |
| FY2021 | $59.5M | -39.1% |
| FY2020 | $97.7M | +1035.7% |
| FY2019 | -$10.4M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026